Snidow JW - Search Results

1

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens.

Swindells S, Cohen CJ, Berger DS, Tashima KT, Liao Q, Pobiner BF, Snidow JW, Pakes GE, Hernandez JE; NZTA4008 Study Team. Swindells S, et al. Among authors: snidow jw. BMC Infect Dis. 2005 Apr 8;5:23. doi: 10.1186/1471-2334-5-23. BMC Infect Dis. 2005. PMID: 15819974 Free PMC article. Clinical Trial.

2

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.

Keiser PH, Sension MG, DeJesus E, Rodriguez A, Olliffe JF, Williams VC, Wakeford JH, Snidow JW, Shachoy-Clark AD, Fleming JW, Pakes GE, Hernandez JE; ESS40003 Study Team. Keiser PH, et al. Among authors: snidow jw. BMC Infect Dis. 2005 Jan 12;5:2. doi: 10.1186/1471-2334-5-2. BMC Infect Dis. 2005. PMID: 15647105 Free PMC article. Clinical Trial.

3

Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.

Al-Harthi L, Voris J, Patterson BK, Becker S, Eron J, Smith KY, D'Amico R, Mildvan D, Snidow J, Pobiner B, Yau L, Landay A. Al-Harthi L, et al. HIV Med. 2004 Jan;5(1):55-65. doi: 10.1111/j.1468-1293.2004.00186.x. HIV Med. 2004. PMID: 14731171 Free article.

4

Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.

Hendrix CW, Wakeford J, Wire MB, Lou Y, Bigelow GE, Martinez E, Christopher J, Fuchs EJ, Snidow JW. Hendrix CW, et al. Among authors: snidow jw. Pharmacotherapy. 2004 Sep;24(9):1110-21. doi: 10.1592/phco.24.13.1110.38091. Pharmacotherapy. 2004. PMID: 15460171 Clinical Trial.

5

The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.

Rainey PM, Friedland GH, Snidow JW, McCance-Katz EF, Mitchell SM, Andrews L, Lane B, Jatlow P. Rainey PM, et al. Among authors: snidow jw. Am J Addict. 2002 Winter;11(1):66-74. doi: 10.1080/10550490252801657. Am J Addict. 2002. PMID: 11876585

6

A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

Jansen JP, Lorch D, Langan J, Lasko B, Hermanns K, Kleoudis CS, Snidow JW, Pierce A, Wurzelmann J, Mortensen ER. Jansen JP, et al. Among authors: snidow jw. J Pain. 2011 Feb;12(2):185-93. doi: 10.1016/j.jpain.2010.06.012. J Pain. 2011. PMID: 21292169 Free article. Clinical Trial.

7

A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.

Irving G, Pénzes J, Ramjattan B, Cousins M, Rauck R, Spierings EL, Kleoudis CS, Snidow JW, Pierce A, Wurzelmann J, Mortensen ER. Irving G, et al. Among authors: snidow jw. J Pain. 2011 Feb;12(2):175-84. doi: 10.1016/j.jpain.2010.06.013. J Pain. 2011. PMID: 21292168 Free article. Clinical Trial.

8

Glaxo presents its views ..

Bauman JH, Snidow JW. Bauman JH, et al. Among authors: snidow jw. Mo Med. 1989 Feb;86(2):71-2. Mo Med. 1989. PMID: 2569666 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters